These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1331590)
1. Antagonistic activity of Y-25130 on 5-HT3 receptors. Sato N; Sakamori M; Haga K; Takehara S; Setoguchi M Jpn J Pharmacol; 1992 Aug; 59(4):443-8. PubMed ID: 1331590 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed. Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266 [TBL] [Abstract][Full Text] [Related]
3. Antagonistic activities of N-3389, a newly synthesized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors. Hagihara K; Hayakawa T; Arai T; Eguchi H; Mino S; Kawase S Eur J Pharmacol; 1994 Dec; 271(1):159-66. PubMed ID: 7698198 [TBL] [Abstract][Full Text] [Related]
4. Blockade of 5-HT3 receptor-mediated currents in dissociated frog sensory neurones by benzoxazine derivative, Y-25130. Yakushiji T; Akaike N Br J Pharmacol; 1992 Nov; 107(3):853-7. PubMed ID: 1472977 [TBL] [Abstract][Full Text] [Related]
5. RS 23597-190: a potent and selective 5-HT4 receptor antagonist. Eglen RM; Bley K; Bonhaus DW; Clark RD; Hegde SS; Johnson LG; Leung E; Wong EH Br J Pharmacol; 1993 Sep; 110(1):119-26. PubMed ID: 8220871 [TBL] [Abstract][Full Text] [Related]
6. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546 [TBL] [Abstract][Full Text] [Related]
7. BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties. Blackburn TP; Baxter GS; Kennett GA; King FD; Piper DC; Sanger GJ; Thomas DR; Upton N; Wood MD Psychopharmacology (Berl); 1993; 110(3):257-64. PubMed ID: 7831418 [TBL] [Abstract][Full Text] [Related]
8. [High affinity binding of Y-25130 for serotonin 3 receptor]. Sakamori M; Takehara S; Setoguchi M Nihon Yakurigaku Zasshi; 1992 Aug; 100(2):137-42. PubMed ID: 1330854 [TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle. Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of 6-chloro-3,4-dihydro-4-methyl-2H-1,4-benzoxazine-8-carboxamide derivatives as potent serotonin-3 (5-HT3) receptor antagonists. Kuroita T; Sakamori M; Kawakita T Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):756-64. PubMed ID: 8681408 [TBL] [Abstract][Full Text] [Related]
14. [Inhibition by Y-25130 of the von Bezold-Jarisch effect evoked by 5-HT or 2-methyl-5-HT in anesthetized rats]. Inaba K; Morimoto Y; Fukuda T; Setoguchi M Nihon Yakurigaku Zasshi; 1991 Oct; 98(4):293-9. PubMed ID: 1802816 [TBL] [Abstract][Full Text] [Related]
15. GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Gale JD; Grossman CJ; Whitehead JW; Oxford AW; Bunce KT; Humphrey PP Br J Pharmacol; 1994 Jan; 111(1):332-8. PubMed ID: 8012715 [TBL] [Abstract][Full Text] [Related]
16. Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197. Wong EH; Bonhaus DW; Wu I; Stefanich E; Eglen RM J Neurochem; 1993 Mar; 60(3):921-30. PubMed ID: 8436978 [TBL] [Abstract][Full Text] [Related]
17. The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues. Butler A; Elswood CJ; Burridge J; Ireland SJ; Bunce KT; Kilpatrick GJ; Tyers MB Br J Pharmacol; 1990 Nov; 101(3):591-8. PubMed ID: 2076479 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacology of 3,4-dihydro-3-oxo-1,4-benzoxazine-8-carboxamide derivatives, a new class of potent serotonin-3 (5-HT3) receptor antagonists. Kawakita T; Kuroita T; Yasumoto M; Sano M; Inaba K; Fukuda T; Tahara T Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):624-30. PubMed ID: 1611677 [TBL] [Abstract][Full Text] [Related]
19. Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides. Youssefyeh RD; Campbell HF; Airey JE; Klein S; Schnapper M; Powers M; Woodward R; Rodriguez W; Golec S; Studt W J Med Chem; 1992 Mar; 35(5):903-11. PubMed ID: 1548679 [TBL] [Abstract][Full Text] [Related]